Lake Street Initiates Coverage On MiMedx Group with Buy Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Brooks O'Neil initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Buy rating and a price target of $12.
March 07, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lake Street analyst Brooks O'Neil has initiated coverage on MiMedx Group with a Buy rating and set a price target of $12.
The initiation of coverage by Lake Street with a Buy rating and a price target significantly higher than the current trading price suggests a positive outlook for MiMedx Group's stock. This analyst endorsement can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100